
News and Insight for Decision-Makers
Editor's Pick
FDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
Continued here
|
On the company dime: smarter reading. Expense Premium.
WorkWorkWorkWork WorkWorkWorkWork WorkWorkWorkWorkPutin in no mood to negotiate, UK spy chief says - WSJ ISTANBUL--The head of Britain's foreign-intelligence agency, MI6, warned that Russian President Vladimir Putin has no desire to end the war in Ukraine, an assessment that follows months in which President Trump tried to push both sides to negotiate a peace deal. WorkWorkWorkTo avoid trial, a short seller puts his hopes on Trump Going to prison is a real risk for Andrew Left. Every day he thinks the Trump administration wouldn't want him to be there.The short seller, known for his feisty Citron Research reports and trades including shorting GameStop during the January 2021 meme-stock trading frenzy, is accused by prosecutors of exploiting his fame to manipulate stocks for quick profits. Work WorkWorkWorkWork WorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWorkWork TradeBriefs Publications are read by over 100,000 Industry Executives About Us | Advertise | Privacy PolicyUnsubscribe You are receiving this mail because of your subscription with TradeBriefs. Our mailing address is 3110 Thomas Ave, Dallas, TX 75204, USA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|